Snacks also provide an opportunity to boost your intake of important nutrients such as protein, fibre and calcium. Young children have small stomachs, so they need to eat frequently to obtain the nutrients they need. Older kids need the added calories to fuel growth, development and physical activity.

Some snacks have the advantage of delivering specific health benefits. Nuts, for example, help lower elevated LDL cholesterol and blood pressure, and may help ward off Type 2 diabetes. Low fat dairy products, rich in calcium, are part of a blood pressure lowering diet (think yogurt, smoothies and lattes).

The trick, of course, is choosing a nutritious snack that will boost your blood sugar and keep it relatively stable until mealtime. Snacks should include carbohydrate to fuel your muscles and brain, along with protein and a little fat to slow digestion and keep you feeling energized longer.

Snacks should also have a low glycemic index (GI). Low GI foods are digested slowly, leading to a gradual rise in blood sugar, helping you feel energetic and satisfied longer.

The first tool to shedding the flab is awareness. You need to be aware of how your system works! Your body is just like a machine that requires a little fuel to make it work for a long time.

The odd working system of our body seems to make us question as to why it’s easy to gain weight than to lose it! Its simple logic, those if you eat more you gain more. Now, where is this logic when we spend hours in the gym and starve ourselves to death trying to lose those unmerciful pounds! Makes you think, doesn’t it?

The first tool to shedding the flab is awareness. You need to be aware of how your system works! Your body is just like a machine that requires a little fuel to make it work for a long time. If you burn the calories you consume- you lose weight. But if you don’t, well…!

The second thing is action. Many of us, even when we are aware of the facts, are too lazy to translate them into reality! Are you one of them? If you are, you should change for your own good. Most people just need an initial boost, a little motivation from people around them and before you know, they are charging towards that fat monster within them!

And how do you take the first step? You should see where you stand. Let your physician decide whether you are overweight or obese. Then decide your diet plan. You don’t have to follow an elaborate diet. Include cereals, juices, salads and vegetables in your meals and cut down on those fattening snacks! Eat healthy and also in the right portions. Just be aware of the basic principles of a good diet and you are ready to go!

You are now having the right foods! What else do you need? Of course the exercise! Sorry folks, but you can’t lose weight without it. If you think going to the gym will be too much for you, you can start with easy exercises like walking or cycling. These are fun too! The more you exercise the easier the weight loss!

You can also turn to weight loss products like diet pills that will facilitate your weight loss program. Diet pills work to make lose weight faster. Pills like alli work as fat absorbents while those like Phentermine work as an appetite suppressant, which means that they curb the desire to overeat and help you lose weight. In addition to that Phentermine also boosts your metabolism and helps you burn calories faster!

But remember diet pills should be combined with two steps, that is, a balanced diet and exercise. Only then will you be able to accomplish your weight loss goals! So, take the first step today and get ready to beat that fat!

Source: http://www.prlog.org/

Immediately is available ACOMPLIA in Germany and beyond that also in Great Britain, Denmark, Ireland, Finland and Norway one offers. The medicine is available for using up as 20-mg tablet, which is taken once on the day before the breakfast. On 21 June 2006 the European commission had given the permission for ACOMPLIA (Rimonabant 20 mg/day) for all 25 member states of the European Union for the following indication:

Additionally to Diät and movement on the treatment of adiposity (BMI> 30 kg/m2) or over-weighty patients (BMI> 27 kg/m2), which exhibits one or more factors of risk beyond that such as Typ-2-Diabetes or Dyslipidämie. ACOMPLIA sanofi aventis one discovered and one developed. It is a first representative of a new class of medicines, the so-called CB1-Antagonisten. Into ACOMPLIA contained active substance the Rimonabant blocks selectively the CB1-Rezeptoren at multiple effect places such as muscles, fatty tissue, liver, stomach, intestine and brain. Accomplia the overactivity of the EC-system restrains and causes in this way a reduction of kardiometabolischer factors of risk like degraded HDL, increased triglycerides, increased HbA1c and increased waist extent:

Over-weighty patients can reduce their body weight clearly by regular income of the new active substance Rimonabant and lower thus their metabolic risk clearly regarding a diabetes or a heart cycle illness. If the effect of the weight reduction could be documented so far only over maximally twelve months, now results of a new study occupy that the reached weight acceptance with Rimonabant can remain also long-term.

Source: http://www.businessportal24.com/ 

Its recent approval for sale in Switzerland has brought droplets of fresh showers on the promising weight loss drug. Lyn Youngman senior marketing executive at Acomplia Rimonabant Pill, “Acomplia conquers yet again with its approval for sale in Switzerland. Although Swiss weight is a small market but nevertheless it marks the spread of Acomplia usage”.

Acomplia received approval for sale in Switzerland on 3rd of April, 2007. it is to used only when other approaches like exercise and regulated dietary habits fail to work in sourcing weight loss. Swiss medical authorities have approved it for usage by individuals with a BMI 30 (obese); and individuals with a BMI 27 with at least one cardio metabolic risk factors.

Weight loss medication, Acomplia is already approved for sale in the UK, France, Germany, Mexico, Ireland, Finland, Norway, Austria, Argentina, amid other countries.

It's now official. If diet drug Acomplia (rimonabant) is ultimately approved for sale in the United States, the prescription diet pill will go on the U.S. market not as Acomplia but as Zimulti.

Sanofi-Aventis, developer of rimonabant which is now sold in a number of European countries, Argentina and Mexico as Acomplia, has long been coy about what name it intends to use if the FDA approves the diet drug for U.S. sale.

But the pros-and-cons of rimonabant are cheduled to be aired by an FDA advisory panel on June 13th, and the official notice of the hearing published in the Federal Register says the panel will discuss "the efficacy and safety of new drug application (NDA) 21-888, proposed tradename Zimulti (rimonabant)."

The meeting notice published by the FDA Endocrinologic and Metabolic Drugs Advisory Committee also is interesting in that would appear to dash suggestions made by some of Sanofi's favorite financial analysts that the FDA may now approve Acomplia / Zimulti for treatment of type 2 diabetes.

Diet drug rimonabant (Acomplia / Zimulti ) was approved for sale on April 3rd by Switzerland for treatment of obese or overweight patients with at least one type of associated cardiovascular risk.

The approval by Switzerland, which is not a member of the European Union, is similar to the EU marketing approval last June, where the drug was cleared for use in combination with diet and exercise for overweight and obese patients with linked health risks such as type 2 diabetes.

Sanofi-Aventis said regulator Swissmedic authorized the use of the drug for "for obese patients (BMI greater than 30) or for overweight patients (BMI over 27) with at least one associated cardiovascular risk factor, after insufficient weight reduction following physical activity or alimentary adaptation."

Switzerland is a relatively small market, and the news of Acomplia's approval hardly offsets recent disappointing announcements on reimbursement by state social security systems in the large EU countries of France and Germany.

Source: http://www.acompliareport.com/